Ceapro Inc. (CVE:CZO – Get Free Report) was down 11.8% during mid-day trading on Friday . The stock traded as low as C$0.23 and last traded at C$0.23. 5,850 shares traded hands during mid-day trading, a decline of 88% from the average session volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Stock Performance
The company has a debt-to-equity ratio of 8.07, a current ratio of 8.54 and a quick ratio of 18.88. The company’s fifty day simple moving average is C$0.22 and its two-hundred day simple moving average is C$0.23. The stock has a market cap of C$688,880.00, a price-to-earnings ratio of -2.83 and a beta of 1.38.
Ceapro Company Profile
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Featured Stories
- Five stocks we like better than Ceapro
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
